8.063 5.55%

Research Hotspot

Click Each Keyword to Figure Out More

Derivative Improve Tool Nir-ii Modification Damage Distribution Lncrna Challenge Landscape Pet Mri Microrna Downregulation Atherosclerosis Prognosis Confers Event Functional Metastatic Impairs Overexpression Infection Motor Perspective Transition Modulation Raman Formulation Sirna Myeloma Polymeric Emission Vaccine Study Hepatic Barrier Proteomics Wnt/β-catenin Stability Link Blockade Nerve Oral Vivo Albumin Akt/mtor Akt Hif-1α Peripheral Against Neuron Fragment Tomography Metabolomics Ferroptosis Image-guided Zinc Regenerative Repair Invasion Mirna Feature Depletion Osteosarcoma Hypoxia Hepatoma Cyanine Nanodots Skeletal Histology Array Ascorbic Emt Promoter Combined Toward Network Isolation Yin Dc Yang Cd36 Formation Imaging-guided Diabetic Disorder Ro Epstein-barr Change Biodistribution Silk Accelerates Mir-21 Sequencing Hedgehog Process Acidic Element Binding Micrornas Generation Cholangiocarcinoma Reactive Ovarian Multi-omics Cascade Spheroid Rodent Stellate Opportunity Characteristic Enhancement Respiration Signature Validation Facilitates Pulposus Luminogen Stemness Trafficking Berberine Energy Level Exosomal Endometriosis Aptamer Mesoporous T Radiosensitizer Ameliorates Nanoprobes Negative Radiotherapy Play Myocardial Syndrome Use Rac1 Cardiomyocyte Influenza Osteoporosis Cluster Sodium Design Protect Accelerate Enzyme Pharmacokinetics Learning Towards Host-guest Acquisition Metabolite Ischemia Niche Type Monoclonal Co-delivery Trigger Myeloid Sensitivity Programmable Side Osteogenesis Inhibit Regulate Triple Death Epithelium Stress Reconstruction Smart Aneurysm Silica Crystalline Prevention On-demand Matter Sox2 Cd44 Intervention Malignancy Size Identifies Mediated T-cells Methylation Repression Medicine Foxm1 Necroptosis Silica-induced Early-stage Epr Sulforaphane Ability Paclitaxel Manganese Absence Prediction Support Heterogeneity Serf Liquid Modulate Identification Radiomics Subset Biopsy Mr Estrogen Recurrence Comparison Lipiodol E Erratum Chemo-radiotherapy Zeb1 Suppressing Mitochondrion Polymerase Gap Reduces Reference Risk Manner Program Multifunctional Radiosensitivity Anti-tumor Pathogen Vegf Cxcr4 Profiling Nanotherapy Provides Hypertrophy Bowel Hollow Microscopy Ganglion Fluid Improved Induce Respiratory Blood-brain Pi3k/akt Aiegens Flow Epidermal Clock Hearing Sepsis Biomimetic Remodeling Optoacoustic Stabilization Line Prevents Lymphocyte Highly Vessel Shell Domain Machine Cdc42 Chemoembolization Noninvasive Integration Interface Ferritin Deficiency Behavior Shape Alteration Nanovector Photothermia Adult Hybrid Circulating Microbiota Pten Psma Tgf-β Integrin Gut Alginate Particle Nanozyme Impaired Cetuximab Cardiomyopathy Status Component Tracer Trail Insight Signal Efficient Osteoclastogenesis Homeostasis Colon Interplay Protective

Theranostics - Impact Factor

The Impact Factor 2018 of Theranostics is 8.063, which is just updated in 2019. Compared with historical Impact Factor, the Impact Factor 2018 of Theranostics dropped by 5.55% . The Impact Factor Quartile of Theranostics is Q1. The Impact Factor (IF) or Journal Impact Factor (JIF) of an academic journal is a scientometric index that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factors are often deemed to be more important than those with lower ones. The Impact Factor measures the average number of citations received in a particular year (2018) by papers published in the journal during the two preceding years (2016-2017). Note that 2018 impact factors are reported in 2019; they cannot be calculated until all of the 2018 publications have been processed by the indexing agency. Besides, 94% scientific research articles published by Theranostics have received at least 1 citation in 2018. In addition to the 2-year Impact Factor, the 3-year Impact Factor and 5-year Impact Factor can provide further insights into the impact of Theranostics.

 Impact Factor 2018-19


Theranostics - Impact Factor Trend Prediction System

Impact Factor Trend Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future journal impact and performance through the wisdom of crowds. Impact Factor Trend Prediction System displays the exact community-driven Data without secret algorithms, hidden factors, or systematic delay.

Theranostics Impact Factor Trend Forecasting System
 Real-Time Impact Factor Prediction & 2017 2018 2019 IF Impact Factor Trend - Academic Accelerator
Theranostics Impact Factor Trend. The chart clearly shows a downtrend of Impact Factor in 2018.
  • Impact Factor 2017 8.537
  • Impact Factor 2016 8.712
  • Impact Factor 2015 8.854

425


  • Article Volume 2017 353
  • Article Volume 2016 171
  • Article Volume 2015 106
  • ISSN
  • 18387640
  • Open Access
  • Publisher
  • Ivyspring International Publisher
  • Country/Region
  • Canada
  • History
  • Categories
  • Medicine (miscellaneous) (Q1), Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)

Theranostics - ISSN

The ISSN of Theranostics is 18387640. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Theranostics - ISSN

Theranostics - Open Access Journal

Theranostics is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Much scientific and medical research is paid for with public funds. Open Access allows taxpayers to see the results of their investment.

Theranostics - Open Access

Theranostics - Publisher

Theranostics is published by Ivyspring International Publisher, which is located in the Canada. The Publication History of Theranostics covers 2012-ongoing.

Theranostics - Publisher

Theranostics - Categories

Theranostics is a peer-reviewed scientific journal. The scope of Theranostics covers Medicine (miscellaneous) (Q1), Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1).

Theranostics - Categories

Theranostics - Journal Metrics

It is impossible to get a true picture of impact using a single metric alone, so a basket of metrics is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Metrics including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the Theranostics.

Theranostics - Journal Metrics

Journal Ranking